Zobrazeno 1 - 5
of 5
pro vyhledávání: '"B. Uzielly"'
Autor:
Harvey M. Golomb, Rose Ruchlemer, Gilles Lugassy, Stephanie F. Williams, Aaron Polliack, B Uzielly, Yaron Ilan
Publikováno v:
Leukemialymphoma. 5(4)
During the past 15 years the treatment of Hodgkin's disease (HD) with chemo/radiotherapy has been shown to appreciably improve the long-term prognosis of patients, even those with more advanced disease. In the past it was accepted that the probabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529f42310af798234c6fdb0ef2f0c57f
https://pubmed.ncbi.nlm.nih.gov/27467847
https://pubmed.ncbi.nlm.nih.gov/27467847
Autor:
David Miles, Martine Baudin, S. Van Belle, B. Uzielly, Philippe Beuzeboc, Moira Shearer, Patrick Squiban, Silvia von Mensdorff-Pouilly, Joyce Taylor-Papadimitriou, Pierre Pouillart, Bruce Acres, Nadine Bizouarne, Susy Scholl
Publikováno v:
Journal of Biomedicine and Biotechnology, 3, 194-201. Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology, Vol 2003, Iss 3, Pp 194-201 (2003)
Scholl, S, Squiban, P, Bizouarne, N, Baudin, M, Acres, B, von Mensdorff-Pouilly, S, Shearer, M, Beuzeboc, P, Belle, S, Uzielly, B, Pouillart, P & Taylor-Papdimitriou, J 2003, ' Metastatic breast tumour regression following treatment by a gene-modified vaccinia virus expression MUC1 and IL-2. ', Journal of Biomedicine and Biotechnology, vol. 3, pp. 194-201 . https://doi.org/10.1155/s111072430320704x
Journal of Biomedicine and Biotechnology
Journal of Biomedicine and Biotechnology, Vol 2003, Iss 3, Pp 194-201 (2003)
Scholl, S, Squiban, P, Bizouarne, N, Baudin, M, Acres, B, von Mensdorff-Pouilly, S, Shearer, M, Beuzeboc, P, Belle, S, Uzielly, B, Pouillart, P & Taylor-Papdimitriou, J 2003, ' Metastatic breast tumour regression following treatment by a gene-modified vaccinia virus expression MUC1 and IL-2. ', Journal of Biomedicine and Biotechnology, vol. 3, pp. 194-201 . https://doi.org/10.1155/s111072430320704x
Journal of Biomedicine and Biotechnology
MUC1 is expressed by glandular epithelial cells. It is overexpressed in the majority of breast tumours, making it a potential target for immune therapy. The objectives of the present study were to evaluate the anti-tumour activity and tolerance of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83046b30eb37f89d28ff551cf207c383
https://doi.org/10.1155/s111072430320704x
https://doi.org/10.1155/s111072430320704x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Scholl S, Squiban P, Bizouarne N, Baudin M, Acres B, Von Mensdorff-Pouilly S, Shearer M, Beuzeboc P, Van Belle S, Uzielly B, Pouillart P, Taylor-Papadimitriou J, Miles D
Publikováno v:
Journal of biomedicine & biotechnology [J Biomed Biotechnol] 2003; Vol. 2003 (3), pp. 194-201.
Autor:
Ilan Y; b Internal Medicine A, Hadassah University Hospital and Hebrew University Hadassah Medical School, Jerusalem, Israel., Ruchlemer R; a Lymphoma Leukemia Unit, Departments of Hematology, Hadassah University Hospital and Hebrew University Hadassah Medical School, Jerusalem, Israel., Lugassy G; d Hematology Service, Barzilai Hospital, Ashkelon., Uzielly B; c Oncology, Hadassah University Hospital and Hebrew University Hadassah Medical School, Jerusalem, Israel., Williams SF; e Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois, USA., Golomb HM; e Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois, USA., Polliack A; a Lymphoma Leukemia Unit, Departments of Hematology, Hadassah University Hospital and Hebrew University Hadassah Medical School, Jerusalem, Israel.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 1991; Vol. 5 (4), pp. 249-54.